Results 81 to 90 of about 7,936 (162)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside [PDF]

, 2017
Dejan Radovanovic, Pierachille Santus, Francesco Blasi, Marco Mantero   +3 more
openalex   +1 more source

A COST-EFFECTIVE ANALYSIS OF TIOTROPIUM WITH FORMOTEROL AND BUDESONIDE WITH FORMOTEROL BASED ON EFFICACY AND QUALITY OF LIFE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS

, 2018
Kameswari Garnepudi, Ivaturi Shravanthi, Keerthana Sivakumar, Maithili Sharma M, Kurakula Manasa   +4 more
openalex   +2 more sources

The Effect of Salmeterol, Tiotropium Bromide and its Combination in Patients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease

, 2020
Mohammad Ali Saba
openalex   +1 more source

Tiotropium for the treatment of asthma: a drug safety evaluation [PDF]

, 2016
Huib A.M. Kerstjens, Paul M. O’Byrne
openalex   +1 more source

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study

International Journal of COPD, 2019
Yoshiaki Minakata,1 Takashi Motegi,2 Jun Ueki,3 Yasuhiro Gon,4 Shuhei Nakamura,5 Tatsuhiko Anzai,6 Kazuto Hirata,7 Masakazu Ichinose81Department of Respiratory Medicine, National Hospital Organization Wakayama Hospital, Wakayama, Japan; 2Department of ...
Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M   +7 more
doaj  

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

, 2022
Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, Lin MS, Chunling Liu, Kuo PH, Tsai YH   +13 more
openalex   +1 more source

Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives [PDF]

, 2018
V. Madhu Chari, Andrew McIvor
openalex   +1 more source

A randomized prospective study to compare the efficacy and safety of budesonide plus formoterol and tiotropium plus formoterol in patients having mild to moderate chronic obstructive pulmonary disease

, 2021
C. Singh, Aditya Kumar Gautam, Alok Dixit, Amit Singh, Sandeep K. Singh   +4 more
openalex   +2 more sources

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD

International Journal of COPD, 2016
Eric Derom, Guy G Brusselle, Guy F Joos Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumAbstract: Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-
Derom E, Brusselle GG, Joos GF
doaj  

Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey

, 2014
Massimiliano Povero, Lorenzo Pradelli, Paola Turco, Roberto W. Dal Negro   +3 more
openalex   +2 more sources